Clinical trial
3D Prediction of Patient-Specific Response
NCT03561207 · KIYATEC, Industry · Unknown status
Key facts
| NCT number | NCT03561207 |
|---|---|
| Title | 3D Prediction of Patient-Specific Response |
| Official title | 3D-PREDICT REGISTRY: 3D Prediction of Patient-specific Response Using Ex Vivo Interrogation of Live Cells From Tumors |
| Acronym | 3D-PREDICT |
| Lead sponsor | KIYATEC, Industry |
| Status | Unknown status |
| Study type | Observational [Patient Registry] |
| Conditions | Advanced Cancer, Ovarian Cancer, Glioblastoma Multiforme, Anaplastic Astrocytoma |
| Intervention type | Diagnostic Test |
| Interventions | EV3D Assay |
| Enrollment | 570 |
| Start date | Jun 11, 2018 |
| Primary completion | Jun 1, 2024 |
| Completion | Dec 1, 2024 |
| First posted | Jun 19, 2018 |
| Last update posted | Mar 24, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: